Radium Capital are delighted to partner with Australia’s leading medtech conference, AusMedtech (brought to you by AusBiotech), supporting the growth of the nation’s medtech and health innovation sectors.
As Australia’s leading R&D finance provider, Radium Capital powers Australian innovators by partnering to provide access to the funding, resources, and connections they need to move from ideas to impact.
Big ideas need deep pockets, and since 2017 Radium Capital has deployed over $1 billion in non-dilutive funding to Australian innovators, providing strategic, simple capital that supports every step of their innovation journey.
Through Radium Advances, businesses can unlock their R&DTI refund early to accelerate commercialisation, reduce capital outlay and attract other funding sources.
Want to know how we can help you by becoming a strategic part of your capital mix? Fill out this form and one of our team will be in contact with you to discuss your specific requirements. Plus, read how our clients have used Radium Advances to fund their R&D and set their businesses up for further success.
Southern RNA
End to end mRNA manufacturing in Australia for life-saving treatments.
Oqea
Supporting clinicians to deliver mental healthcare faster; reducing wait times and optimising the patient care journey.
BioFactura
Clinical trials in Australia and New Zealand delivering treatment breakthroughs for patients.
NeedleCalm
Making needle-related procedures easier for patients and healthcare practitioners.Get in Touch with Radium
For more information about Radium Advances, or to chat with the team please send us a message